Reduce Inflamation with Symprove

An independent trial carried out at King’s College, London on 80 patients with ulcerative colitis taking Symprove has concluded that 76% of these patients had a reduced level of inflammation after only 4 weeks.       

Professor Bjarnason presented this information at Digestive Disease Week in Washington yesterday and it was received extremely well. This is a significant result as it reinforces the science behind our product and will hopefully give you even greater confidence to recommend Symprove to your IBD patients.


 Click here to see the Symprove product page!